Abnormal dendritic calcium activity and synaptic depotentiation occur early in a mouse model of Alzheimer’s disease

Abstract Background Alzheimer’s disease (AD) is characterized by amyloid deposition, tangle formation as well as synapse loss. Synaptic abnormalities occur early in the pathogenesis of AD. Identifying early synaptic abnormalities and their underlying mechanisms is likely important for the prevention...

Full description

Bibliographic Details
Main Authors: Yang Bai, Miao Li, Yanmei Zhou, Lei Ma, Qian Qiao, Wanling Hu, Wei Li, Zachary Patrick Wills, Wen-Biao Gan
Format: Article
Language:English
Published: BMC 2017-11-01
Series:Molecular Neurodegeneration
Subjects:
Online Access:http://link.springer.com/article/10.1186/s13024-017-0228-2
id doaj-7a924d09f8b749d2aee61762c03c021c
record_format Article
spelling doaj-7a924d09f8b749d2aee61762c03c021c2020-11-24T22:02:26ZengBMCMolecular Neurodegeneration1750-13262017-11-0112111510.1186/s13024-017-0228-2Abnormal dendritic calcium activity and synaptic depotentiation occur early in a mouse model of Alzheimer’s diseaseYang Bai0Miao Li1Yanmei Zhou2Lei Ma3Qian Qiao4Wanling Hu5Wei Li6Zachary Patrick Wills7Wen-Biao Gan8Drug Discovery Center, Key Laboratory of Chemical Genomics, Peking University Shenzhen Graduate SchoolDrug Discovery Center, Key Laboratory of Chemical Genomics, Peking University Shenzhen Graduate SchoolDrug Discovery Center, Key Laboratory of Chemical Genomics, Peking University Shenzhen Graduate SchoolDrug Discovery Center, Key Laboratory of Chemical Genomics, Peking University Shenzhen Graduate SchoolDrug Discovery Center, Key Laboratory of Chemical Genomics, Peking University Shenzhen Graduate SchoolDrug Discovery Center, Key Laboratory of Chemical Genomics, Peking University Shenzhen Graduate SchoolDrug Discovery Center, Key Laboratory of Chemical Genomics, Peking University Shenzhen Graduate SchoolDepartment of Neurobiology, University of PittsburghDrug Discovery Center, Key Laboratory of Chemical Genomics, Peking University Shenzhen Graduate SchoolAbstract Background Alzheimer’s disease (AD) is characterized by amyloid deposition, tangle formation as well as synapse loss. Synaptic abnormalities occur early in the pathogenesis of AD. Identifying early synaptic abnormalities and their underlying mechanisms is likely important for the prevention and treatment of AD. Methods We performed in vivo two-photon calcium imaging to examine the activities of somas, dendrites and dendritic spines of layer 2/3 pyramidal neurons in the primary motor cortex in the APPswe/PS1dE9 mouse model of AD and age-matched wild type control mice. We also performed calcium imaging to determine the effect of Aβ oligomers on dendritic calcium activity. In addition, structural and functional two-photon imaging were used to examine the link between abnormal dendritic calcium activity and changes in dendritic spine size in the AD mouse model. Results We found that somatic calcium activities of layer 2/3 neurons were significantly lower in the primary motor cortex of 3-month-old APPswe/PS1dE9 mice than in wild type mice during quiet resting, but not during running on a treadmill. Notably, a significantly larger fraction of apical dendrites of layer 2/3 pyramidal neurons showed calcium transients with abnormally long duration and high peak amplitudes during treadmill running in AD mice. Administration of Aβ oligomers into the brain of wild type mice also induced abnormal dendritic calcium transients during running. Furthermore, we found that the activity and size of dendritic spines were significantly reduced on dendritic branches with abnormally prolonged dendritic calcium transients in AD mice. Conclusion Our findings show that abnormal dendritic calcium transients and synaptic depotentiation occur before amyloid plaque formation in the motor cortex of the APPswe/PS1dE9 mouse model of AD. Dendritic calcium transients with abnormally long durations and high amplitudes could be induced by soluble Aβ oligomers and contribute to synaptic deficits in the early pathogenesis of AD.http://link.springer.com/article/10.1186/s13024-017-0228-2Alzheimer’s diseaseDendritic calcium activityTwo-photon imagingAPPswe/PS1dE9Soluble Aβ oligomersSynaptic depotentiation
collection DOAJ
language English
format Article
sources DOAJ
author Yang Bai
Miao Li
Yanmei Zhou
Lei Ma
Qian Qiao
Wanling Hu
Wei Li
Zachary Patrick Wills
Wen-Biao Gan
spellingShingle Yang Bai
Miao Li
Yanmei Zhou
Lei Ma
Qian Qiao
Wanling Hu
Wei Li
Zachary Patrick Wills
Wen-Biao Gan
Abnormal dendritic calcium activity and synaptic depotentiation occur early in a mouse model of Alzheimer’s disease
Molecular Neurodegeneration
Alzheimer’s disease
Dendritic calcium activity
Two-photon imaging
APPswe/PS1dE9
Soluble Aβ oligomers
Synaptic depotentiation
author_facet Yang Bai
Miao Li
Yanmei Zhou
Lei Ma
Qian Qiao
Wanling Hu
Wei Li
Zachary Patrick Wills
Wen-Biao Gan
author_sort Yang Bai
title Abnormal dendritic calcium activity and synaptic depotentiation occur early in a mouse model of Alzheimer’s disease
title_short Abnormal dendritic calcium activity and synaptic depotentiation occur early in a mouse model of Alzheimer’s disease
title_full Abnormal dendritic calcium activity and synaptic depotentiation occur early in a mouse model of Alzheimer’s disease
title_fullStr Abnormal dendritic calcium activity and synaptic depotentiation occur early in a mouse model of Alzheimer’s disease
title_full_unstemmed Abnormal dendritic calcium activity and synaptic depotentiation occur early in a mouse model of Alzheimer’s disease
title_sort abnormal dendritic calcium activity and synaptic depotentiation occur early in a mouse model of alzheimer’s disease
publisher BMC
series Molecular Neurodegeneration
issn 1750-1326
publishDate 2017-11-01
description Abstract Background Alzheimer’s disease (AD) is characterized by amyloid deposition, tangle formation as well as synapse loss. Synaptic abnormalities occur early in the pathogenesis of AD. Identifying early synaptic abnormalities and their underlying mechanisms is likely important for the prevention and treatment of AD. Methods We performed in vivo two-photon calcium imaging to examine the activities of somas, dendrites and dendritic spines of layer 2/3 pyramidal neurons in the primary motor cortex in the APPswe/PS1dE9 mouse model of AD and age-matched wild type control mice. We also performed calcium imaging to determine the effect of Aβ oligomers on dendritic calcium activity. In addition, structural and functional two-photon imaging were used to examine the link between abnormal dendritic calcium activity and changes in dendritic spine size in the AD mouse model. Results We found that somatic calcium activities of layer 2/3 neurons were significantly lower in the primary motor cortex of 3-month-old APPswe/PS1dE9 mice than in wild type mice during quiet resting, but not during running on a treadmill. Notably, a significantly larger fraction of apical dendrites of layer 2/3 pyramidal neurons showed calcium transients with abnormally long duration and high peak amplitudes during treadmill running in AD mice. Administration of Aβ oligomers into the brain of wild type mice also induced abnormal dendritic calcium transients during running. Furthermore, we found that the activity and size of dendritic spines were significantly reduced on dendritic branches with abnormally prolonged dendritic calcium transients in AD mice. Conclusion Our findings show that abnormal dendritic calcium transients and synaptic depotentiation occur before amyloid plaque formation in the motor cortex of the APPswe/PS1dE9 mouse model of AD. Dendritic calcium transients with abnormally long durations and high amplitudes could be induced by soluble Aβ oligomers and contribute to synaptic deficits in the early pathogenesis of AD.
topic Alzheimer’s disease
Dendritic calcium activity
Two-photon imaging
APPswe/PS1dE9
Soluble Aβ oligomers
Synaptic depotentiation
url http://link.springer.com/article/10.1186/s13024-017-0228-2
work_keys_str_mv AT yangbai abnormaldendriticcalciumactivityandsynapticdepotentiationoccurearlyinamousemodelofalzheimersdisease
AT miaoli abnormaldendriticcalciumactivityandsynapticdepotentiationoccurearlyinamousemodelofalzheimersdisease
AT yanmeizhou abnormaldendriticcalciumactivityandsynapticdepotentiationoccurearlyinamousemodelofalzheimersdisease
AT leima abnormaldendriticcalciumactivityandsynapticdepotentiationoccurearlyinamousemodelofalzheimersdisease
AT qianqiao abnormaldendriticcalciumactivityandsynapticdepotentiationoccurearlyinamousemodelofalzheimersdisease
AT wanlinghu abnormaldendriticcalciumactivityandsynapticdepotentiationoccurearlyinamousemodelofalzheimersdisease
AT weili abnormaldendriticcalciumactivityandsynapticdepotentiationoccurearlyinamousemodelofalzheimersdisease
AT zacharypatrickwills abnormaldendriticcalciumactivityandsynapticdepotentiationoccurearlyinamousemodelofalzheimersdisease
AT wenbiaogan abnormaldendriticcalciumactivityandsynapticdepotentiationoccurearlyinamousemodelofalzheimersdisease
_version_ 1725835840516521984